{"abstract":"The Food and Drug Administration (FDA or the Agency) is extending the comment period for the proposed rule entitled \"Labeling Requirements for Approved or Conditionally Approved New Animal Drugs\" published in the Federal Register of March 12, 2024, by 60 days. The Agency is taking this action in response to a request for an extension to allow interested persons additional time to submit comments.","action":"Proposed rule; extension of comment period.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2024/05/22/2024-11229.html","cfr_references":[{"chapter":null,"citation_url":null,"part":"201","title":21},{"chapter":null,"citation_url":null,"part":"500","title":21},{"chapter":null,"citation_url":null,"part":"501","title":21},{"chapter":null,"citation_url":null,"part":"510","title":21},{"chapter":null,"citation_url":null,"part":"514","title":21},{"chapter":null,"citation_url":null,"part":"516","title":21}],"citation":"89 FR 44944","comment_url":null,"comments_close_on":"2024-08-09","correction_of":null,"corrections":[],"dates":"FDA is extending the comment period on the proposed rule published March 12, 2024 (89 FR 18262), by 60 days. Either electronic or written comments must be submitted by August 9, 2024.","disposition_notes":null,"docket_ids":["Docket No. FDA-2023-N-5160"],"dockets":[{"supporting_documents":[{"title":"Reference 1 Preliminary Regulatory Impact Initial Regulatory Flexibility and Unfunded Mandates Reform Act Analyses 2023 Docket No FDA-2023-N-5160","document_id":"FDA-2023-N-5160-0003"},{"title":"Reference 9 AVMA Pet Ownership Sourcebook 2017 2018 Table S1 Fig. 2","document_id":"FDA-2023-N-5160-0002"}],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2024-05-22","updated_at":"2024-09-03T17:01:17.452-04:00","comment_url":"https://www.regulations.gov/commenton/FDA-2023-N-5160-0011","allow_late_comments":false,"id":"FDA-2023-N-5160-0011","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":2,"id":"FDA-2023-N-5160","title":"Labeling Requirements for Approved or Conditionally Approved New Animal Drugs"}],"document_number":"2024-11229","effective_on":null,"end_page":44945,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2024/05/22/2024-11229.xml","html_url":"https://www.federalregister.gov/documents/2024/05/22/2024-11229/labeling-requirements-for-approved-or-conditionally-approved-new-animal-drugs-extension-of-comment","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2024-11229?publication_date=2024-05-22","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2024-05-22/2024-11229/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":467,"last_updated":"2026-10-25 12:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-05-22/pdf/2024-11229.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-11229.pdf?1716295524","publication_date":"2024-05-22","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2024/05/22/2024-11229.txt","regulation_id_number_info":{"0910-AI43":{"issue":"202504","html_url":"https://www.federalregister.gov/regulations/0910-AI43/labeling-requirements-for-approved-or-conditionally-approved-new-animal-drugs","title":"Labeling Requirements for Approved or Conditionally Approved New Animal Drugs","xml_url":"http://www.reginfo.gov/public/do/eAgendaViewRule?pubId=202504&RIN=0910-AI43&operation=OPERATION_EXPORT_XML","priority_category":"Substantive, Nonsignificant"}},"regulation_id_numbers":["0910-AI43"],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Reference 1 Preliminary Regulatory Impact Initial Regulatory Flexibility and Unfunded Mandates Reform Act Analyses 2023 Docket No FDA-2023-N-5160","document_id":"FDA-2023-N-5160-0003"},{"title":"Reference 9 AVMA Pet Ownership Sourcebook 2017 2018 Table S1 Fig. 2","document_id":"FDA-2023-N-5160-0002"}],"regulatory_plan":{"html_url":"https://www.federalregister.gov/regulations/0910-AI43/labeling-requirements-for-approved-or-conditionally-approved-new-animal-drugs","title":"Labeling Requirements for Approved or Conditionally Approved New Animal Drugs"},"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2023-N-5160","supporting_documents_count":2,"docket_id":"FDA-2023-N-5160","document_id":"FDA-2023-N-5160-0011","regulation_id_number":"0910-AI43","title":"Labeling Requirements for Approved or Conditionally Approved New Animal Drugs","checked_regulationsdotgov_at":"2024-05-23T15:00:08Z"},"regulations_dot_gov_url":null,"significant":false,"signing_date":null,"start_page":44944,"subtype":null,"title":"Labeling Requirements for Approved or Conditionally Approved New Animal Drugs; Extension of Comment Period","toc_doc":"Labeling Requirements for Approved or Conditionally Approved New Animal Drugs","toc_subject":null,"topics":[],"type":"Proposed Rule","volume":89}